ONMD vs. LUNA, NOTV, BIAF, AIKI, DKDCA, ISPC, FOXO, IQV, ICLR, and INCY
Should you be buying OneMedNet stock or one of its competitors? The main competitors of OneMedNet include Luna Innovations (LUNA), Inotiv (NOTV), bioAffinity Technologies (BIAF), AIkido Pharma (AIKI), Data Knights Acquisition (DKDCA), iSpecimen (ISPC), FOXO Technologies (FOXO), IQVIA (IQV), ICON Public (ICLR), and Incyte (INCY). These companies are all part of the "commercial physical research" industry.
OneMedNet (NASDAQ:ONMD) and Luna Innovations (NASDAQ:LUNA) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, valuation, institutional ownership, earnings, media sentiment, risk, profitability, analyst recommendations and dividends.
OneMedNet has a net margin of 0.00% compared to Luna Innovations' net margin of -1.82%. Luna Innovations' return on equity of 3.61% beat OneMedNet's return on equity.
Luna Innovations has higher revenue and earnings than OneMedNet. Luna Innovations is trading at a lower price-to-earnings ratio than OneMedNet, indicating that it is currently the more affordable of the two stocks.
Luna Innovations received 199 more outperform votes than OneMedNet when rated by MarketBeat users.
1.0% of OneMedNet shares are owned by institutional investors. Comparatively, 87.5% of Luna Innovations shares are owned by institutional investors. 45.7% of OneMedNet shares are owned by insiders. Comparatively, 7.6% of Luna Innovations shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Luna Innovations has a consensus price target of $10.00, suggesting a potential upside of 199.40%. Given Luna Innovations' higher probable upside, analysts plainly believe Luna Innovations is more favorable than OneMedNet.
OneMedNet has a beta of -0.46, indicating that its stock price is 146% less volatile than the S&P 500. Comparatively, Luna Innovations has a beta of 1.4, indicating that its stock price is 40% more volatile than the S&P 500.
In the previous week, Luna Innovations had 14 more articles in the media than OneMedNet. MarketBeat recorded 18 mentions for Luna Innovations and 4 mentions for OneMedNet. OneMedNet's average media sentiment score of 1.29 beat Luna Innovations' score of 0.35 indicating that OneMedNet is being referred to more favorably in the media.
Summary
Luna Innovations beats OneMedNet on 11 of the 16 factors compared between the two stocks.
Get OneMedNet News Delivered to You Automatically
Sign up to receive the latest news and ratings for ONMD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ONMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
OneMedNet Competitors List
Related Companies and Tools
